SCHEMBL18939632

SCHEMBL18939632

CCc1sc(N2CCN(C(=O)OC(C)(C)C)CC2)nc1-c1ccc(C(=O)OC)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CKS1B P61024 2/20 0.46
SKP1 P63208 2/20 0.46
SKP2 Q13309 2/20 0.46
PKM P14618 1/20 0.45
AR P10275 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.41
MAPT P10636 2/20 0.41
LMNA P02545 1/20 0.41
GPR119 Q8TDV5 2/20 0.40
MEN1 O00255 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
HDAC4 P56524 1/20 0.40
PGK1 P00558 1/20 0.40
PIK3CA P42336 1/20 0.40
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ACKR3 P25106 1/20 0.39
ATM Q13315 1/20 0.39
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1146996 0.87 CKS1B (0.46) CKS1BSKP1SKP2PKMAR
SCHEMBL3767883 0.87 CKS1B (0.61) CKS1BSKP1SKP2ARMAPT
SCHEMBL16075325 0.82 CKS1B (0.47) CKS1BSKP1SKP2PKMSMN1; SMN2
SCHEMBL19909690 0.77 GPR119 (0.46) CKS1BSKP1SKP2SMN1; SMN2MAPT
SCHEMBL1146899 0.77 CKS1B (0.50) CKS1BSKP1SKP2ARSMN1; SMN2
SCHEMBL16075324 0.76 JAK2 (0.48) CKS1BSKP1SKP2GPR119
SCHEMBL20767954 0.76 NPC1 (0.55) SMN1; SMN2MAPTLMNAMEN1CYP2C19
SCHEMBL3100957 0.76 KMT2A (0.64) CKS1BSKP1SKP2SMN1; SMN2MAPT
SCHEMBL6132325 0.76 MAPT (0.58) PKMSMN1; SMN2MAPTLMNAGPR119
SCHEMBL16075326 0.76 ALDH1A1 (0.50) CKS1BSKP1SKP2SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170166538-A1 PROTEASE INHIBITORS MEDIVIR AB (SE) 2017-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170166538-A1 PROTEASE INHIBITORS MMP8, CTSK, CTSS CKS1B 305/4885SKP1 839/4885SKP2 1099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.